Analytical Data
-
Gene name
bbgII
- Application
-
Alternative Names
(Beta-gal)
-
Species
Bifidobacterium bifidum
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A5A2I5
-
Expression Region
1-689aa
-
Molecular Weight
84.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BBGII is a recombinant protein that has garnered significant attention in the field of biochemical research due to its potential applications in various biotechnological and therapeutic domains. Originating from the BBGII gene, this protein is involved in critical biological processes, including cell signaling and interaction with specific receptors. The study of BBGII is particularly relevant in the context of diseases where these pathways are disrupted, such as cancer and autoimmune disorders. Researchers aim to understand the structural and functional properties of BBGII to elucidate its role in cellular mechanisms. Furthermore, the recombinant production of BBGII allows for detailed investigations into its interactions with other biomolecules, paving the way for the development of novel diagnostic tools and therapeutic strategies. Advances in genetic engineering and protein expression techniques have facilitated the large-scale production of BBGII, providing a platform for rigorous scientific studies. The insights gained from BBGII research not only contribute to the fundamental understanding of protein biology but also hold promising implications for drug development and the improvement of existing treatments. As such, BBGII remains a focal point of research in the quest to leverage protein engineering for medical and industrial applications.
